These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 23642997)

  • 1. Relationship between levels of angiogenic and lymphangiogenic factors and the endoscopic, histological and clinical activity, and acute-phase reactants in patients with inflammatory bowel disease.
    Algaba A; Linares PM; Fernández-Contreras ME; Ordoñez A; Trápaga J; Guerra I; Chaparro M; de la Poza G; Gisbert JP; Bermejo F
    J Crohns Colitis; 2013 Dec; 7(11):e569-79. PubMed ID: 23642997
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Is ischemia modified albumin a disease activity marker for inflammatory bowel diseases?
    Kaplan M; Yuksel M; Ates I; Kilic ZM; Kilic H; Kuzu UB; Kayacetin E
    J Gastroenterol Hepatol; 2016 Jun; 31(6):1120-5. PubMed ID: 26642816
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-inflammatory effects of pancreatitis associated protein in inflammatory bowel disease.
    Gironella M; Iovanna JL; Sans M; Gil F; Peñalva M; Closa D; Miquel R; Piqué JM; Panés J
    Gut; 2005 Sep; 54(9):1244-53. PubMed ID: 15870231
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects of infliximab or adalimumab on vascular endothelial growth factor and angiopoietin 1 angiogenic factor levels in inflammatory bowel disease: serial observations in 37 patients.
    Algaba A; Linares PM; Encarnación Fernández-Contreras M; Figuerola A; Calvet X; Guerra I; de Pousa I; Chaparro M; Gisbert JP; Bermejo F
    Inflamm Bowel Dis; 2014 Apr; 20(4):695-702. PubMed ID: 24562175
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of vascular endothelial growth factor and angiopoietin systems in serum of Crohn's disease patients.
    Pousa ID; Maté J; Salcedo-Mora X; Abreu MT; Moreno-Otero R; Gisbert JP
    Inflamm Bowel Dis; 2008 Jan; 14(1):61-7. PubMed ID: 17879276
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Elevated levels of serum-soluble triggering receptor expressed on myeloid cells-1 in patients with IBD do not correlate with intestinal TREM-1 mRNA expression and endoscopic disease activity.
    Saurer L; Rihs S; Birrer M; Saxer-Seculic N; Radsak M; Mueller C;
    J Crohns Colitis; 2012 Oct; 6(9):913-23. PubMed ID: 22410349
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased production of vascular endothelial growth factor by intestinal mucosa of patients with inflammatory bowel disease.
    Griga T; Voigt E; Gretzer B; Brasch F; May B
    Hepatogastroenterology; 1999; 46(26):920-3. PubMed ID: 10370639
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Angiogenesis as a novel component of inflammatory bowel disease pathogenesis.
    Danese S; Sans M; de la Motte C; Graziani C; West G; Phillips MH; Pola R; Rutella S; Willis J; Gasbarrini A; Fiocchi C
    Gastroenterology; 2006 Jun; 130(7):2060-73. PubMed ID: 16762629
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impaired Intestinal Permeability Contributes to Ongoing Bowel Symptoms in Patients With Inflammatory Bowel Disease and Mucosal Healing.
    Chang J; Leong RW; Wasinger VC; Ip M; Yang M; Phan TG
    Gastroenterology; 2017 Sep; 153(3):723-731.e1. PubMed ID: 28601482
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum interleukin-18 concentrations in patients with inflammatory bowel disease.
    Furuya D; Yagihashi A; Komatsu M; Masashi N; Tsuji N; Kobayashi D; Watanabe N
    J Immunother; 2002; 25 Suppl 1():S65-7. PubMed ID: 12048353
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correlation between soluble triggering receptor expressed on myeloid cells-1 (sTREM-1) expression and endoscopic activity in inflammatory bowel diseases.
    Jung YS; Park JJ; Kim SW; Hong SP; Kim TI; Kim WH; Cheon JH
    Dig Liver Dis; 2012 Nov; 44(11):897-903. PubMed ID: 22721842
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel, objective, multivariate biomarkers composed of plasma amino acid profiles for the diagnosis and assessment of inflammatory bowel disease.
    Hisamatsu T; Okamoto S; Hashimoto M; Muramatsu T; Andou A; Uo M; Kitazume MT; Matsuoka K; Yajima T; Inoue N; Kanai T; Ogata H; Iwao Y; Yamakado M; Sakai R; Ono N; Ando T; Suzuki M; Hibi T
    PLoS One; 2012; 7(1):e31131. PubMed ID: 22303484
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Necroptosis is active in children with inflammatory bowel disease and contributes to heighten intestinal inflammation.
    Pierdomenico M; Negroni A; Stronati L; Vitali R; Prete E; Bertin J; Gough PJ; Aloi M; Cucchiara S
    Am J Gastroenterol; 2014 Feb; 109(2):279-87. PubMed ID: 24322838
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship between serum interleukin-17 level and inflammatory bowel disease.
    Liu QL; Huang L; Zhao QJ; Li Q; He Z
    J Biol Regul Homeost Agents; 2016; 30(1):181-8. PubMed ID: 27049090
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of inflammatory bowel disease activity in children using serum trefoil factor peptide.
    Teng X; Yang Y; Liu L; Yang L; Wu J; Sun M; Xu L
    Pediatr Res; 2020 Nov; 88(5):792-795. PubMed ID: 32120375
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum VEGF and bFGF in patients with inflammatory bowel diseases.
    Kopanakis N; Saiti A; D'Avgerinos E; Masselou K; Simiri M; Mandaraka A; Vasiliadis G; Katergiannakis V
    Ann Ital Chir; 2014; 85(3):203-6. PubMed ID: 25073576
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rapid fecal calprotectin level assessment and the SIBDQ score can accurately detect active mucosal inflammation in IBD patients in clinical remission: a prospective study.
    Voiosu T; Benguş A; Dinu R; Voiosu AM; Bălănescu P; Băicuş C; Diculescu M; Voiosu R; Mateescu B
    J Gastrointestin Liver Dis; 2014 Sep; 23(3):273-8. PubMed ID: 25267955
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum tenascin-C is an indicator of inflammatory bowel disease activity.
    Riedl S; Tandara A; Reinshagen M; Hinz U; Faissner A; Bodenmüller H; Buhr HJ; Herfarth C; Möller P
    Int J Colorectal Dis; 2001 Sep; 16(5):285-91. PubMed ID: 11686525
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum ST2 in inflammatory bowel disease: a potential biomarker for disease activity.
    Boga S; Alkim H; Koksal AR; Ozagari AA; Bayram M; Tekin Neijmann S; Sen I; Alkim C
    J Investig Med; 2016 Jun; 64(5):1016-24. PubMed ID: 27001944
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Could platelet indices be new biomarkers for inflammatory bowel diseases?
    Öztürk ZA; Dag MS; Kuyumcu ME; Cam H; Yesil Y; Yilmaz N; Aydinli M; Kadayifci A; Kepekci Y
    Eur Rev Med Pharmacol Sci; 2013 Feb; 17(3):334-41. PubMed ID: 23426536
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.